| The cancer metabolic reprogramming and immune response L Xia, L Oyang, J Lin, S Tan, Y Han, N Wu, P Yi, L Tang, Q Pan, S Rao, ... Molecular cancer 20, 1-21, 2021 | 542 | 2021 |
| PARP inhibitor resistance: the underlying mechanisms and clinical implications H Li, ZY Liu, N Wu, YC Chen, Q Cheng, J Wang Molecular cancer 19, 1-16, 2020 | 361 | 2020 |
| PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer T Hong, G Lei, X Chen, H Li, X Zhang, N Wu, Y Zhao, Y Zhang, J Wang Redox biology 42, 101928, 2021 | 186 | 2021 |
| TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K/AKT oncogenic signaling L Liu, N Wu, Y Wang, X Zhang, B Xia, J Tang, J Cai, Z Zhao, Q Liao, ... Journal of Experimental & Clinical Cancer Research 38, 1-15, 2019 | 116 | 2019 |
| MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway C Fang, YX Chen, NY Wu, JY Yin, XP Li, HS Huang, W Zhang, HH Zhou, ... Scientific reports 7 (1), 40384, 2017 | 91 | 2017 |
| Progesterone prevents high-grade serous ovarian cancer by inducing necroptosis of p53-defective fallopian tube epithelial cells NY Wu, HS Huang, TH Chao, HM Chou, C Fang, CZ Qin, CY Lin, TY Chu, ... Cell reports 18 (11), 2557-2565, 2017 | 71 | 2017 |
| Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential X Xu, Q Peng, X Jiang, S Tan, Y Yang, W Yang, Y Han, Y Chen, L Oyang, ... Experimental & Molecular Medicine 55 (7), 1357-1370, 2023 | 42 | 2023 |
| Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women Y Tian, NYY Wu, YL Liou, CT Yeh, L Cao, YN Kang, HJ Wang, Y Li, ... Oncotarget 8 (37), 62274, 2017 | 42 | 2017 |
| The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity J Lin, L Xia, L Oyang, J Liang, S Tan, N Wu, P Yi, Q Pan, S Rao, Y Han, ... Oncogene 41 (7), 1024-1039, 2022 | 41 | 2022 |
| Combined clinical and genetic testing algorithm for cervical cancer diagnosis YL Liou, TL Zhang, T Yan, CT Yeh, YN Kang, L Cao, N Wu, CF Chang, ... Clinical epigenetics 8, 1-11, 2016 | 41 | 2016 |
| Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics Q Peng, Y Zhou, L Oyang, N Wu, Y Tang, M Su, X Luo, Y Wang, X Sheng, ... Molecular Therapy 30 (3), 1018-1035, 2022 | 39 | 2022 |
| Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions NYY Wu, C Fang, HS Huang, J Wang, TY Chu Modern Pathology 33 (1), 29-37, 2020 | 38 | 2020 |
| TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation Y Chen, L Liu, L Xia, N Wu, Y Wang, H Li, X Chen, X Zhang, Z Liu, M Zhu, ... Journal of Experimental & Clinical Cancer Research 41 (1), 44, 2022 | 36 | 2022 |
| Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment S Tan, Y Yang, W Yang, Y Han, L Huang, R Yang, Z Hu, Y Tao, L Liu, Y Li, ... Journal of Experimental & Clinical Cancer Research 42 (1), 59, 2023 | 33 | 2023 |
| MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation CZ Qin, XY Lou, QL Lv, L Cheng, NY Wu, L Hu, HH Zhou Die Pharmazie-An International Journal of Pharmaceutical Sciences 70 (10 …, 2015 | 32 | 2015 |
| Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis J Mei, H Tian, HS Huang, CF Hsu, Y Liou, N Wu, W Zhang, TY Chu Cell proliferation 54 (5), e13029, 2021 | 31 | 2021 |
| Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice CZ Qin, QL Lv, NY Wu, L Cheng, YC Chu, TY Chu, L Hu, Y Cheng, ... Journal of ethnopharmacology 168, 146-149, 2015 | 30 | 2015 |
| Genetic variation of CYP3A5 influences paclitaxel/carboplatin‐induced toxicity in Chinese epithelial ovarian cancer patients L Hu, QL Lv, Y Guo, L Cheng, NY Wu, CZ Qin, HH Zhou The Journal of Clinical Pharmacology 56 (3), 349-354, 2016 | 28 | 2016 |
| SOX2OT, a novel tumor-related long non-coding RNA Y Wang, N Wu, X Luo, X Zhang, Q Liao, J Wang Biomedicine & Pharmacotherapy 123, 109725, 2020 | 27 | 2020 |
| High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis NYY Wu, X Zhang, T Chu, S Zhu, Y Deng, Y Zhou, Y Wang, X Zhao, L Liu, ... Annals of Translational Medicine 7 (14), 2019 | 25 | 2019 |
